• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 752

Preparation containing the bacterial monophages, BP-63 and LVR16-A, specific to Salmonella

Intended Use: For use as an antimicrobial processing aid
Basis: Scientific procedures
Notifier: Phagelux, Inc.
Notifier Address: 1600 Royalmount
Montreal, Quebec, H4P 2R2
GRAS Notice (releasable information): GRN 752 (in PDF) (2 MB)
Date of closure: Jul 13, 2018
FDA's Letter: FDA has no questions (in PDF) (57 kB)
Additional correspondence: Jan 7, 2022
Supplemental Letter (130 kB)